» Articles » PMID: 21940166

Chemical Scaffolds with Structural Similarities to Siderophores of Nonribosomal Peptide-polyketide Origin As Novel Antimicrobials Against Mycobacterium Tuberculosis and Yersinia Pestis

Overview
Specialty Biochemistry
Date 2011 Sep 24
PMID 21940166
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Mycobacterium tuberculosis (Mtb) and Yersinia pestis (Yp) produce siderophores with scaffolds of nonribosomal peptide-polyketide origin. Compounds with structural similarities to these siderophores were synthesized and evaluated as antimicrobials against Mtb and Yp under iron-limiting conditions mimicking the iron scarcity these pathogens encounter in the host and under standard iron-rich conditions. Several new antimicrobials were identified, including some with increased potency in the iron-limiting condition. Our study illustrates the possibility of screening compound libraries in both iron-rich and iron-limiting conditions to identify antimicrobials that may selectively target iron scarcity-adapted bacteria and highlights the usefulness of building combinatorial libraries of compounds having scaffolds with structural similarities to siderophores to feed into antimicrobial screening programs.

Citing Articles

Rationally Designed Novel Phenyloxazoline Synthase Inhibitors: Chemical Synthesis and Biological Evaluation to Accelerate the Discovery of New Antimycobacterial Antibiotics.

Shyam M, Bhattacharje G, Daniel C, Kumar A, Yadav P, Mukherjee P Molecules. 2023; 28(24).

PMID: 38138601 PMC: 10745776. DOI: 10.3390/molecules28248115.


In Silico Drug Repurposing Studies for the Discovery of Novel Salicyl-AMP Ligase (MbtA)Inhibitors.

Rakshit G, Biswas A, Jayaprakash V Pathogens. 2023; 12(12).

PMID: 38133316 PMC: 10745912. DOI: 10.3390/pathogens12121433.


Targeting iron-scavenging tools: a recent update on siderophores inhibitors.

Kumar G, Adhikrao P RSC Med Chem. 2023; 14(10):1885-1913.

PMID: 37859726 PMC: 10583813. DOI: 10.1039/d3md00201b.


Mutants with a Compromised Functional Link between the Type VII ESX-3 System and an Iron Uptake Mechanism Reliant on an Unusual Mycobactin Siderophore.

Bythrow G, Farhat M, Levendosky K, Mohandas P, Germain G, Yoo B Pathogens. 2022; 11(9).

PMID: 36145386 PMC: 9505556. DOI: 10.3390/pathogens11090953.


Antibiotic Therapy of Plague: A Review.

Sebbane F, Lemaitre N Biomolecules. 2021; 11(5).

PMID: 34065940 PMC: 8151713. DOI: 10.3390/biom11050724.


References
1.
Gokhan N, Yesilada A, Ucar G, Erol K, Bilgin A . 1-N-substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: synthesis and evaluation as MAO inhibitors. Arch Pharm (Weinheim). 2003; 336(8):362-71. DOI: 10.1002/ardp.200300732. View

2.
Rodriguez G, Smith I . Identification of an ABC transporter required for iron acquisition and virulence in Mycobacterium tuberculosis. J Bacteriol. 2005; 188(2):424-30. PMC: 1347291. DOI: 10.1128/JB.188.2.424-430.2006. View

3.
Klayman D, Bartosevich J, Griffin T, Mason C, Scovill J . 2-Acetylpyridine thiosemicarbazones. 1. A new class of potential antimalarial agents. J Med Chem. 1979; 22(7):855-62. DOI: 10.1021/jm00193a020. View

4.
Dye C . Global epidemiology of tuberculosis. Lancet. 2006; 367(9514):938-40. DOI: 10.1016/S0140-6736(06)68384-0. View

5.
Quadri L . Assembly of aryl-capped siderophores by modular peptide synthetases and polyketide synthases. Mol Microbiol. 2000; 37(1):1-12. DOI: 10.1046/j.1365-2958.2000.01941.x. View